EGFR wild type antagonizes EGFRvIII-mediated activation of Met in glioblastoma.

MLA

Li, L., et al. “EGFR Wild Type Antagonizes EGFRvIII-Mediated Activation of Met in Glioblastoma.” Oncogene, vol. 34, no. 1, Jan. 2015, pp. 129–34. EBSCOhost, https://doi.org/10.1038/onc.2013.534.

APA

Li, L., Puliyappadamba, V. T., Chakraborty, S., Rehman, A., Vemireddy, V., Saha, D., Souza, R. F., Hatanpaa, K. J., Koduru, P., Burma, S., Boothman, D. A., & Habib, A. A. (2015). EGFR wild type antagonizes EGFRvIII-mediated activation of Met in glioblastoma. Oncogene, 34(1), 129–134. https://doi.org/10.1038/onc.2013.534

Chicago

Li, L, V T Puliyappadamba, S Chakraborty, A Rehman, V Vemireddy, D Saha, R F Souza, et al. 2015. “EGFR Wild Type Antagonizes EGFRvIII-Mediated Activation of Met in Glioblastoma.” Oncogene 34 (1): 129–34. doi:10.1038/onc.2013.534.